Business Wire

THALES

25.1.2021 10:02:13 CET | Business Wire | Press release

Share
NATO Selects Thales to Supply Its First Defence Cloud for the Armed Forces

NATO has selected Thales to provide the first certified defence cloud solution that can be deployed in the theatre of operations in less than 24 hours. Thales was selected after a worldwide competitive tendering process on the basis of its defence systems integration know-how. With this contract, the Group enters a new market sector and demonstrating its capacity to integrate the best civil and commercial technologies available and to adapt them to the needs of the armed forces.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210125005006/en/

As military operations become increasingly data-driven, access to critical data and applications is a crucial requirement for the armed forces. The defence cloud developed by Thales enables the forces to analyse and share data in real time from the command centre to the theatre of operations, pursue their digital transformation in complete security, and accelerate the decision cycle to gain and maintain an operational advantage.

Until now, it could take several months and dozens of specialised engineers working at sites close to the combat zone to deploy the assets required. With Nexium Defence Cloud and its Service Design Studio and orchestration system, a small team of experts can deploy IT services and applications to locations thousands of kilometres away in just a few hours. This solution is based on a holistic approach encompassing applications management, IT, networks and security, with an overall system architecture designed to accommodate various different levels of confidentiality.

Nexium Defence Cloud incorporates the best civil and commercial technologies available to provide a complete, modular, sovereign solution that enables forces to operate fully autonomously in the theatre of operations. It offers a wide array of possible configurations, from very high-capacity and easily scalable infrastructure for command headquarters to all-in-one containerised systems that transform a forward base into a new cloud node in just a few hours.

This easy interconnection within ad hoc organisations and command structures increases mission effectiveness with an unparalleled level of security.

Nexium Defence Cloud is the most compact, highly integrated and modular solution available today. It includes all the components of military command posts (cabinets, servers, data storage media, supervision system, etc.) and meets performance requirements in terms of size, weight and power (SWaP) to simplify deployment and minimise the logistics footprint.

Through this contract, Thales once again demonstrates its system certification and standardisation know-how. Its defence cloud solution was designed to comply with the requirements of NATO's Federated Mission Networking (FMN) standard, which establishes the framework for cooperation between command-and-control networks for coalition forces. Nexium Defence Cloud has all the strengths needed to become the benchmark solution for the high-value-added deployable command posts that will be required for the coalition operations of tomorrow.

"Thales is proud to be contributing to the digital transformation of the armed forces by providing this first deployable, certified, tactical defence cloud solution. We are grateful to NATO for renewing their trust in our expertise in secure, interoperable information and communication systems." Marc Darmon , Executive Vice-President, Secure Communications and Information Systems, Thales.

About Thales

Thales (Euronext Paris: HO) is a global high technology leader investing in digital and “deep tech” innovations – connectivity, big data, artificial intelligence, cybersecurity and quantum technology – to build a future we can all trust, which is vital to the development of our societies. The company provides solutions, services and products that help its customers – businesses, organisations and states – in the defence, aeronautics, space, transportation and digital identity and security markets to fulfil their critical missions, by placing humans at the heart of the decision-making process.

With 83,000 employees in 68 countries, Thales generated sales of €19 billion in 2019 (on a basis including Gemalto over 12 months).

PLEASE VISIT
Thales Group
Market

Link:

ClickThru

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

SLB and Vår Energi Expand Digital Collaboration to Scale Well and Integrated Field Development Planning28.5.2026 13:47:00 CEST | Press release

Agreement supports Vår Energi’s ambition to reduce time to first oil, building on multi-discipline, collaborative well planning workflows that reduce cycle times from months to days Global energy technology company SLB (NYSE: SLB) today announced an expanded collaboration with Vår Energi to scale well planning and integrated field development planning across its Norwegian Continental Shelf operations. With collaborative well planning already reducing cycle times from months to days and integrated field development planning expected to support similar benefits, the expanded deployment is designed to support faster, more consistent decision-making as operators work to sustain production from mature offshore assets while managing increasing development complexity. As part of the expanded collaboration, Vår Energi is deploying the Delfi™ digital platform to connect exploration, subsurface evaluation, well planning, subsea design, field development planning, and production in a cloud-native

Kinaxis Convenes Global Supply Chain Leaders at Kinexions North America to Advance Agentic AI and Decision Orchestration28.5.2026 13:00:00 CEST | Press release

Annual conference brings customers, partners, and industry leaders together to explore how enterprises are turning decisions into coordinated action Kinaxis® (TSX:KXS), a global leader in end-to-end supply chain planning and orchestration, is set to host Kinexions North America kicking off next week from June 1-3 at The Cosmopolitan of Las Vegas. The company’s flagship conference will bring together global supply chain, business and technology leaders for three days of product innovation, customer insights, and peer networking as Kinaxis continues to advance its focus on AI-driven decision making across the supply chain industry. This year’s event will spotlight how organizations are applying agentic AI and orchestration, moving beyond insight to execution, and increasingly from decisions to coordinated action. Speakers from global organizations including Merck, Bristol Myers Squibb, Unilever, British American Tobacco, Qualcomm, ExxonMobil, The Hershey Company, Scotts Miracle-Gro, and

Amadeus Redefines Travel Advertising to Help Brands Capture Demand Earlier28.5.2026 13:00:00 CEST | Press release

Developed in collaboration with Accenture, the AI-powered platform helps travel brands make smarter advertising decisions earlier and drive profitable demand through greater control, transparency, efficiency and performance. Amadeus today introduced the Amadeus Travel Advertising Platform at its Advertising Summit in Nice, France. Leveraging Accenture’s agentic framework for campaign execution, the platform outlines a new approach designed to help travel companies make faster, smarter advertising decisions based on where demand is forming — not just where it has already converted. Travel advertising has become increasingly complex, fragmented across channels and often driven by historical performance signals that arrive too late to capture emerging demand. As travelers plan trips across AI chatbots, search, social, metasearch, content platforms and OTAs long before booking, travel brands face rising acquisition costs and growing pressure to prove return on investment. The Amadeus Trave

Compass Pathways Elects Kathleen Tregoning to Board of Directors28.5.2026 12:30:00 CEST | Press release

Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, today announced the election of Kathleen Tregoning to its Board of Directors at the annual general meeting of shareholders. Ms. Tregoning is expected to serve on the Compensation and Leadership Development Committee and the Nominating and Corporate Governance Committee. She brings extensive experience guiding biopharmaceutical companies through periods of growth and transformation, with expertise spanning corporate strategy, external affairs, public policy and patient access. “With two successful Phase 3 trials meeting the primary endpoint, a transformative clinical profile for COMP360, and a rolling NDA submission and review now underway, Compass is strongly positioned to make our goal of securing an FDA approval a reality. Compass is entering a stage where experience in external engagement, public policy, and patient access matters more

Alzprotect Announces FDA Clearance of IND for AZP2006 (Ezeprogind®) in Progressive Supranuclear Palsy (PSP)28.5.2026 12:28:00 CEST | Press release

IND enables initiation of U.S. clinical development in PSP Alzprotect today announced that the U.S. Food and Drug Administration (FDA) has cleared the Company’s Investigational New Drug (IND) application for AZP2006 (Ezeprogind®) for the treatment of Progressive Supranuclear Palsy (PSP). FDA clearance permits the Company to begin clinical development of AZP2006 in the United States. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260526387210/en/ “FDA IND clearance is a pivotal step in our PSP program,” said Philippe Verwaerde, PhD, President & Chief science Officer. “We can now expand our clinical efforts in the U.S. to evaluate AZP2006’s potential to address PSP, a severe neurodegenerative disease with no approved disease-modifying therapies.” Dr. Artin Karapet, Chief Medical Officer, commented: “The FDA’s clearance of our IND for AZP2006 is a pivotal milestone, aligning U.S. and European regulatory pathways and enabling th

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye